4//SEC Filing
Nadav Eran 4
Accession 0000899243-19-012650
CIK 0001563880other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 5:00 PM ET
Size
5.7 KB
Accession
0000899243-19-012650
Insider Transaction Report
Form 4
Nadav Eran
Director
Transactions
- Award
Stock Option (right to buy)
2019-05-07+23,684→ 23,684 totalExercise: $10.00Exp: 2029-05-06→ Common Stock (23,684 underlying)
Footnotes (1)
- [F1]This option was granted on May 7, 2019, effective upon the pricing of the Issuer's initial public offering. This option is scheduled to vest as to (i) 50% of the underlying shares on the earlier of (A) the first anniversary of the date of grant and (B) the date of the first annual meeting of stockholders of the Issuer held following the date of grant and (ii) the remaining 50% of the underlying shares on the earlier of (A) the second anniversary of the date of grant and (B) the date of the second annual meeting of stockholders of the Issuer held following the date of grant.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001587852
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 5:00 PM ET
- Size
- 5.7 KB